<?xml version="1.0" encoding="UTF-8"?>
<p>CRC can be classified into several subtypes based on molecular markers such as 
 <italic>RAS</italic> and 
 <italic>BRAF</italic> mutations, the CpG island methylator phenotype (CIMP), and mismatch repair deficiency (dMMR).
 <xref rid="cas14841-bib-0007" ref-type="ref">
  <sup>7</sup>
 </xref>, 
 <xref rid="cas14841-bib-0008" ref-type="ref">
  <sup>8</sup>
 </xref>, 
 <xref rid="cas14841-bib-0009" ref-type="ref">
  <sup>9</sup>
 </xref>, 
 <xref rid="cas14841-bib-0010" ref-type="ref">
  <sup>10</sup>
 </xref> To date, however, no biomarkers have been determined for selection of OX or IRI. There are several classification methods based on gene‚Äêexpression profiles of tumor tissues such as consensus molecular subtypes of colorectal cancer (CMS) 
 <xref rid="cas14841-bib-0011" ref-type="ref">
  <sup>11</sup>
 </xref> and advanced colorectal cancer subtypes (aCRCS).
 <xref rid="cas14841-bib-0012" ref-type="ref">
  <sup>12</sup>
 </xref>
</p>
